LOS ANGELES, August 23, 2012 /PRNewswire/ --
The MD&M Minneapolis exposition and conference for medical devices this year will feature the MedTech Cardio conference, specifically designed for the cardiovascular device manufacturing audience. The conference will address key issues in cardiovascular device design and manufacturing. MedTech Cardio takes place over two days on October 30 and 31, 2012 at the Minneapolis Convention Center, alongside our MD&M event. For more information, visit http://www.medtechcardio.com
"As the largest and fastest-growing sector of medical equipment, the cardiovascular device industry is bolstered by key trends such as the world's aging population, new therapeutic areas, and rapid technological advances in materials, design and technologies. The sector is not without challenges, however. Cardiovascular devices' high-risk profile impacts every aspect of product development and manufacturing. Meticulously assessing and effectively mitigating risk can be a daunting task. MedTech Cardio is a forum tailored to the designers and makers of cardiovascular devices created to provide practical information to overcome the challenges faced by the industry on a daily basis," said Brian Buntz, Editor-at-Large, MD+DI and Conference Chair at MedTech Cardio.
"MedTech Cardio gathers a highly selective group of more than 20 speakers who are industry leaders, experts and visionaries in the cardiovascular device field," said Vu Nguyen, Conference Program Director. Participants will join 19+ sessions covering the most critical issues in the development and manufacturing of next-generation cardiovascular devices. Unlike other cardiology conferences, this unique meeting is geared towards R&D, Product Development, Process Development, Engineering, Quality Control, and Business Development professionals at medtech companies that are focused on cardiovascular device manufacturing.
Dr. Francis Duhay, Chief Medical Officer at Edwards Lifesciences, will give a keynote speech on the overview of the cardiovascular device industry and major market trends. Some notable speakers joining Dr. Duhay include Dr. Peter Fitzgerald-a renowned cardiologist-inventor from Stanford University and a member of the FDA Medical Device Advisory Board, Josiah Wilcox-Chief Scientific Officer for the CardioVascular Group at Medtronic, Bridget Hurley-Director of R&D at Abbott Vascular, Sanjeev Kulkarni-R&D Fellow at Boston Scientific, and Dr. Dave Albert-Founder of AliveCor and Former Chief Clinical Scientist at GE Cardiology. For a full list of the speaking faculty at MedTech Cardio, visit http://www.medtechcardio.com
Topics at MedTech Cardio 2012 include:
- FDA compliance, updates on 510(k) and user fees for high-risk cardiovascular devices
- Recently proposed UDI rules, track-and-trace capabilities for quality control
- Biomaterial trends, biocompatibility of materials, new biomedical woven textiles
- ASTM test methods and computer modeling systems for risk management and quality control
- Nanotechnology and future DES design, ePTFE coating technique
- Cardiovascular regeneration/tissue engineering
- Sensor-enhanced CRMs and minimally invasive catheters
- Consumerization of cardiovascular devices
MedTech Cardio (http://www.medtechcardio.com) is developed by MD&M (http://www.canontradeshows.com), and in association with MD+DI (http://www.mddinonline.com), a leading publication for OEMs of medical devices and diagnostic products. MedTech Cardio 2012 is co-located with the MD&M Minneapolis tradeshow and conference. For more information about the MD&M Minneapolis event, visit http://www.mdmminn.com. Cite code MJ when registering.
SOURCE UBM Canon